Stem cells and regenerative medicine for the treatment of type 1 diabetes: The challenges lying ahead

Pediatric Diabetes, Supplement

Volumn 5, Issue 2, 2004, Pages 88-93

  Lechner, Andreas ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Beta cells; Insulin secretion; Islet transplantation; Stem cells; Tissue regeneration; Vasculature

Indexed keywords

INSULIN;

ARTICLE; CELL DIFFERENTIATION; CELL REGENERATION; CLINICAL TRIAL; EMBRYONIC STEM CELL; HUMAN; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; METABOLIC REGULATION; NONHUMAN; PANCREAS ISLET; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; REGULATORY MECHANISM; SIDE EFFECT; STEM CELL TRANSPLANTATION; TISSUE REGENERATION;

EID: 11444260233     PISSN: 17451426     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-543x.2004.00084.x     Document Type: Article

References (42)

1. Sutherland DE, Gruessner RW, Dunn DL et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001: 233: 463-501.
2. Ryan EA, Lakey JR, Paty BW et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002: 51: 2148-2157.
3. Bonner-Weir S, Taneja M, Weir GC et al. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 2000: 97: 7999-8004.
4. Gao R, Ustinov J, Pulkkinen MA, Lundin K, Korsgren O, Otonkoski T. Characterization of endocrine progenitor cells and critical factors for their differentiation in human adult pancreatic cell culture. Diabetes 2003: 52: 2007-2015.
5. Abraham EJ, Leech CA, Lin JC, Zulewski H, Habener JF. Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells. Endocrinology 2002: 143: 3152-3161.
6. Suzuki A, Nakauchi H, Taniguchi H. Prospective isolation of multipotent pancreatic progenitors using flow-cytometric cell sorting. Diabetes 2004: 53: 2143-2152.
7. Assady S, Maor G, Amit M, Itskovitz-Eldor J, Skorecki KL, Tzukerman M. Insulin production by human embryonic stem cells. Diabetes 2001: 50: 1691-1697.
8. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001: 292: 1389-1394.
9. Kahan BW, Jacobson LM, Hullett DA et al. Pancreatic precursors and differentiated islet cell types from murine embryonic stem cells: an in vitro model to study islet differentiation. Diabetes 2003: 52: 2016-2024.
10. Ramiya VK, Maraist M, Arfors KE, Schatz DA, Peck AB, Cornelius JG. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med 2000: 6: 278-282.
11. Yang L, Li S, Hatch H et al. In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci USA 2002: 99: 8078-8083.
12. Tang DQ, Cao LZ, Burkhardt BR et al. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 2004: 53: 1721-1732.
13. Soria B, Roche E, Berna G, Leon-Quinto T, Reig JA, Martin F. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 2000: 49: 157-162.
14. Hori Y, Rulifson IC, Tsai BC, Heit JJ, Cahoy JD, Kim SK. Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci USA 2002: 19: 19.
15. BlyszczuK P, Czyz J, Kania G et al. Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc Natl Acad Sci USA 2003: 100: 998-1003.
16. Rajagopal J, Anderson WJ, Kume S, Martines OI, Melton DA. Insulin staining of ES cell progeny from insulin uptake. Science 2003: 299: 363.
17. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993: 329: 977-986.
18. Steil GM, Panteleon AE, Rebrin K. Closed-loop insulin delivery-the path to physiological glucose control. Adv Drug Deliv Rev 2004: 56: 125-144.
19. Manuel DG, Schultz SE. Using linked data to calculate summary measures of population health: Health-adjusted life expectancy of people with diabetes mellitus. Popul Health Metr 2004: 2: 4.
20. Harvey JN, Allagoa B. The long-term renal and retinal outcome of childhood-onset type 1 diabetes. Diabet Med 2004: 21: 26-31.
21. Group tdcactr. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 1996: 45: 1289-1298.
22. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003: 290: 2159-2167.
23. Navarro X, Sutherland DE, Kennedy WR. Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 1997: 42: 727-736.
24. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998: 339: 69-75.
25. Heine RJ, Balkau B, Ceriello A, Del Prato S, Horton ES, Taskinen MR. What does postprandial hyperglycaemia mean? Diabet Med 2004: 21: 208-213.
26. Porksen N. The in vivo regulation of pulsatile insulin secretion. Diabetologia 2002: 45: 3-20.
27. Rorsman P, Renstrom E. Insulin granule dynamics in pancreatic beta cells. Diabetologia 2003: 46: 1029-1045.
28. Ishihara H, Maechler P, Gjinovci A, Herrera PL, Wollheim CB. Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells. Nat Cell Biol 2003: 5: 330-335.
29. Kleinman R, Ohning G, Wong H, Watt P, Walsh J, Brunicardi FC. Regulatory role of intraislet somatostatin on insulin secretion in the isolated perfused human pancreas. Pancreas 1994: 9: 172-178.
30. Bonner-Weir S, Orci L. New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 1982: 31: 883-889.
31. Suschek C, Fehsel K, Kroncke KD, Sommer A, Kolb-Bachofen V. Primary cultures of rat islet capillary endothelial cells. Constitutive and cytokine-inducible macrophage-like nitric oxide synthases are expressed and activities regulated by glucose concentration. Am J Pathol 1994: 145: 685-695.
32. Brissova M, Fowler M, Wiebe P et al. Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets. Diabetes 2004: 53: 1318-1325.
33. Ahren B, Holst JJ. The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia. Diabetes 2001: 50: 1030-1038.
34. Secchi A, Caldara R, Caumo A et al. Cephalic-phase insulin and glucagon release in normal subjects and in patients receiving pancreas transplantation. Metabolism 1995: 44: 1153-1158.
35. Berthoud HR, Trimble ER, Siegel EG, Bereiter DA, Jeanrenaud B. Cephalic-phase insulin secretion in normal and pancreatic islet-transplanted rats. Am J Physiol 1980: 238: E336-E340.
36. Creutzfeldt W. The entero-insular axis in type 2 diabetes - incretins as therapeutic agents. Exp Clin Endocrinol Diabetes 2001: 109 (Suppl. 2): S288-S303.
37. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004: 429: 41-46.
38. Steele C, Hagopian WA, Gitelman S et al. Insulin secretion in type 1 diabetes. Diabetes 2004: 53: 426-433.
39. Nikolic B, Takeuchi Y, Leykin I, Fudaba Y, Smith RN, Sykes M. Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity. Diabetes 2004: 53: 376-383.
40. Ogawa N, List JF, Habener JF, Maki T. Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4. Diabetes 2004: 53: 1700-1705.
41. Bell GI, Polonsky KS. Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 2001: 414: 788-791.
42. Porksen N, Nyholm B, Veldhuis JD, Butler PC, Schmitz O. In humans at least 75% of insulin secretion arises from punctuated insulin secretory bursts. Am J Physiol 1997: 273: E908-E914.